Salix Pharmaceuticals Ltd. (SLXP) Tops Q1 EPS Views
Tweet Send to a Friend
Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) reported Q1 EPS of $0.34, $0.16 better than the analyst estimate of $0.18. Revenue for the quarter came in at $105.9 million versus the consensus estimate of $108.73 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Factset Research Systems (FDS) Reports In-Line Q3 EPS; Guides Q4 EPS, Revs
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
- Smithfield Foods, Inc. (SFD) Posts Q4 EPS of 21c; Sales Top Views
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
